Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
Lightpoint Medical, a leading medical device company developing and marketing miniaturized imaging and sensing tools for minimally-invasive and robot-assisted surgery, announced today that it has signed a strategic collaboration agreement with Telix Pharmaceuticals Limited. Read More →
Lightpoint Medical Announces $8 Million in Funding to Support Commercial Launch of its Robotic Cancer Detection Probe
Lightpoint Medical, a medical device company developing miniaturized cancer detection tools for robot-assisted surgery, announced today that it has completed an $8 million financing round. Read More →
Lightpoint’s SENSEI robotic gamma probe gains CE mark for sentinel lymph node detection
Lightpoint Medical announced Wednesday that its SENSEI robotic gamma probe received the CE mark for intra-operative detection of sentinel lymph nodes. The company said the approval makes SENSEI the first robotic gamma probe to be commercially available to hospitals in Europe. Read More →
Lightpoint Medical shines with £5M investment
Lightpoint Medical has secured a £5 million round from backers including Envestors and Cambridge Capital Group. The startup, which develops intraoperative molecular imaging and sensing technology, plans to use the funds to boost commercial growth. https://pitchbook.com/newsletter/lightpoint-medical-shines-with-5m-investment
CROWDFUNDING: The 5 most successful crowdfunding campaigns in 2017
2017 was a banner year for crowdfunding campaigns. Here are five of the most successful crowdfunding campaigns last year that you need to know about.
Lightpoint Medical Announces Global License Agreement With the University of Arizona
Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology. The licensing process was facilitated by Tech Launch Arizona, the office of the UA that commercializes inventions stemming from University research.
Lightpoint Medical receives 2.4M Euro grant
Lightpoint Medical Receives 2.4M Euro Grant to Support Clinical Study Aiming to Cut Breast Cancer Re-Operation Rates. Lightpoint Medical will evaluate the LightPath™ Imaging System as a means of identifying cancer in a study involving over 300 breast cancer patients involving several hospitals in the UK, Germany, and France.
Lightpoint Medical’s LightPathTM Imaging System is CE marked
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath™ Imaging System is now CE marked, enabling the launch of the device in Europe. ... "Bringing LightPath™ to market is an important milestone in our efforts to transform cancer surgery."
Lightpoint Medical’s LightPath Imaging System now CE marked
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath™ Imaging System is now CE marked, enabling the launch of the device in Europe. “We are delighted to have achieved the major landmark of... Read More →
Lightpoint Medical and PartnerTech sign global manufacturing agreement
Lightpoint Medical's agreement with PartnerTech was signed by both parties in May, and is a major milestone for Lightpoint as they prepare for the launch of LightPath™ later in 2015. “